COVID-19 inpatients with gastrointestinal onset: sex and care needs' differences in the district of Ferrara, Italy.
COVID-19
Coronavirus infection
Digestive symptoms
Gastrointestinal onset
SARS-CoV-2
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
03 Aug 2021
03 Aug 2021
Historique:
received:
29
10
2020
accepted:
27
07
2021
entrez:
4
8
2021
pubmed:
5
8
2021
medline:
25
9
2021
Statut:
epublish
Résumé
COVID-19 is characterized by interstitial pneumonia, but a presentation of the disease with digestive symptoms only may occur. This work was aimed at evaluating: (1) the prevalence of presentation with digestive symptoms only in our cohort of COVID-19 inpatients; (2) differences between patients with and without gastrointestinal onset; (3) differences among males and females with gastrointestinal presentation; (4) outcomes of the groups of subjects with and without gastrointestinal onset. We retrospectively divided the patients hospitalized with COVID-19 into two groups: (1) the one with digestive symptoms (DSG) and (2) the other without digestive symptoms (NDSG). We compared the subjects of DSG with those of NDSG and males with females in the DSG group only, in terms of demographics (age, sex), inflammation and organ damage indexes, length of stay, in-hospital and 100-day mortality. The prevalence of gastrointestinal symptoms at presentation was 12.5%. The DSG group showed a prevalence of females, and these tended to a shorter hospital stay; DSG patients were younger and with a higher load of comorbidities, but no differences concerning inflammation and organ damage indexes, need for intensification of care, in-hospital and 100-day mortality were detected. Among DSG patients, males were younger than females, more comorbid, with higher serum CRP and showed a longer length of hospital stay. Survival functions of DSG patients, in general, are more favourable than those of NDSG if adjusted for sex, age and comorbidities. (1) The prevalence of gastrointestinal presentation among hospitalized COVID-19 patients was 12.5%; (2) DSG patients were on average younger, more comorbid and with a prevalence of females, with a shorter hospital stay; (3) in the DSG group, males had a higher Charlson Comorbidity Score and needed a longer hospital stay; (4) DSG subjects seem to survive longer than those of the NDSG group.
Sections du résumé
BACKGROUND
BACKGROUND
COVID-19 is characterized by interstitial pneumonia, but a presentation of the disease with digestive symptoms only may occur. This work was aimed at evaluating: (1) the prevalence of presentation with digestive symptoms only in our cohort of COVID-19 inpatients; (2) differences between patients with and without gastrointestinal onset; (3) differences among males and females with gastrointestinal presentation; (4) outcomes of the groups of subjects with and without gastrointestinal onset.
METHOD
METHODS
We retrospectively divided the patients hospitalized with COVID-19 into two groups: (1) the one with digestive symptoms (DSG) and (2) the other without digestive symptoms (NDSG). We compared the subjects of DSG with those of NDSG and males with females in the DSG group only, in terms of demographics (age, sex), inflammation and organ damage indexes, length of stay, in-hospital and 100-day mortality.
RESULTS
RESULTS
The prevalence of gastrointestinal symptoms at presentation was 12.5%. The DSG group showed a prevalence of females, and these tended to a shorter hospital stay; DSG patients were younger and with a higher load of comorbidities, but no differences concerning inflammation and organ damage indexes, need for intensification of care, in-hospital and 100-day mortality were detected. Among DSG patients, males were younger than females, more comorbid, with higher serum CRP and showed a longer length of hospital stay. Survival functions of DSG patients, in general, are more favourable than those of NDSG if adjusted for sex, age and comorbidities.
CONCLUSIONS
CONCLUSIONS
(1) The prevalence of gastrointestinal presentation among hospitalized COVID-19 patients was 12.5%; (2) DSG patients were on average younger, more comorbid and with a prevalence of females, with a shorter hospital stay; (3) in the DSG group, males had a higher Charlson Comorbidity Score and needed a longer hospital stay; (4) DSG subjects seem to survive longer than those of the NDSG group.
Identifiants
pubmed: 34344331
doi: 10.1186/s12879-021-06476-y
pii: 10.1186/s12879-021-06476-y
pmc: PMC8329637
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
739Informations de copyright
© 2021. The Author(s).
Références
EClinicalMedicine. 2020 Jun 18;24:100419
pubmed: 32766538
Mol Cell Proteomics. 2014 Feb;13(2):397-406
pubmed: 24309898
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
J Immunol. 2017 Mar 1;198(5):1782-1790
pubmed: 28223406
Am J Epidemiol. 2011 Mar 15;173(6):676-82
pubmed: 21330339
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
J Gastroenterol. 2021 May;56(5):409-420
pubmed: 33759041
World J Gastroenterol. 2020 May 21;26(19):2323-2332
pubmed: 32476796
Mol Syst Biol. 2020 Jul;16(7):e9610
pubmed: 32715618
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Mayo Clin Proc. 2020 Aug;95(8):1632-1648
pubmed: 32753138
Gastroenterology. 2020 Jul;159(1):320-334.e27
pubmed: 32407808
Clin Immunol. 2020 May;214:108393
pubmed: 32222466
Gastroenterology. 2020 May;158(6):1831-1833.e3
pubmed: 32142773
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Lancet. 2020 Feb 15;395(10223):514-523
pubmed: 31986261
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Am J Cardiol. 2021 May 1;146:99-106
pubmed: 33539857
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Gastroenterology. 2020 Jul;159(1):81-95
pubmed: 32251668
Gut. 2020 Jun;69(6):997-1001
pubmed: 32241899
Semin Immunopathol. 2017 Jul;39(5):529-539
pubmed: 28466096
Front Med (Lausanne). 2020 Oct 30;7:588711
pubmed: 33195352
Allergy. 2020 Jul;75(7):1730-1741
pubmed: 32077115
J Trop Pediatr. 2021 May 17;67(2):
pubmed: 34050766
Ann Ist Super Sanita. 2016 Apr-Jun;52(2):198-204
pubmed: 27364394